-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WlAvHi/W6NAod65VvIPDULMSNzlZ/rvNbkOY4Fwmby/e7raMJVRT/+tajt9sDsLG pbNnAqWOaFHZNZJ4EKrlOQ== 0001454189-09-000002.txt : 20091022 0001454189-09-000002.hdr.sgml : 20091022 20091022171124 ACCESSION NUMBER: 0001454189-09-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20091022 DATE AS OF CHANGE: 20091022 EFFECTIVENESS DATE: 20091022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Auspex Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001454189 IRS NUMBER: 954862842 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-126470 FILM NUMBER: 091133024 BUSINESS ADDRESS: STREET 1: 1261 LIBERTY WAY STREET 2: SUITE C CITY: CARLSBAD STATE: CA ZIP: 92081-8356 BUSINESS PHONE: (760) 599-1800 MAIL ADDRESS: STREET 1: 1261 LIBERTY WAY STREET 2: SUITE C CITY: CARLSBAD STATE: CA ZIP: 92081-8356 D 1 primary_doc.xml X0603 D LIVE 0001454189 Auspex Pharmaceuticals, Inc. 1261 LIBERTY WAY SUITE C Vista CA 92081-8356 (760) 599-1800 DELAWARE None None Corporation true 2007 Pratik Shah c/o Auspex Pharmaceuticals, Inc. 1261 Liberty Way, Suite C Vista CA 92081-8356 Executive Officer Director David Collier c/o CMEA Ventures One Embarcadero Center, Suite 3250 San Francisco CA 94111 Director Sep Sarshar c/o Auspex Pharmaceuticals, Inc. 1261 Liberty Way, Suite C Vista CA 92081-8356 Director Sam Sachs c/o Auspex Pharmaceuticals, Inc. 1261 Liberty Way, Suite C Vista CA 92081-8356 Director R. Gary Gilmore c/o Auspex Pharmaceuticals, Inc. 1261 Liberty Way, Suite C Vista CA 92081-8356 Executive Officer Andreas Sommers c/o Auspex Pharmaceuticals, Inc. 1261 Liberty Way, Suite C Vista CA 92081-8356 Executive Officer Ron Newbold c/o Auspex Pharmaceuticals, Inc. 1261 Liberty Way, Suite C Vista CA 92081-8356 Executive Officer Pharmaceuticals Decline to Disclose 06 false 2009-10-09 false true true true Promissory Notes convertible into Preferred Stock and Warrants to purchase shares of Preferred Stock were issued in connection with the Offering. false 0 2000000 2000000 0 No additional consideration was received for the issuance of the warrants. The aggregate number of warrant shares issuable upon exercise of the warrants is contingent upon a formula set forth in each of the warrants. false 5 0 0 0 false Auspex Pharmaceuticals, Inc. R. Gary Gilmore R. Gary Gilmore CFO and Secretary 2009-10-22 -----END PRIVACY-ENHANCED MESSAGE-----